Literature DB >> 32278129

Novel lncRNA XLOC_032768 alleviates cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α.

Xiangjun Zhou1, Kun Jiang1, Haijun Luo2, Cheng Wu1, Weimin Yu1, Fan Cheng3.   

Abstract

The cellular and molecular mechanisms through which cisplatin induces nephrotoxicity have been investigated extensively. However, the role of long non-coding RNAs (lncRNAs) in cisplatin-induced nephrotoxicity is not well known. We explored the functions and underlying mechanisms of a novel lncRNA XLOC_032768 in cisplatin-induced nephrotoxicity. Cisplatin treatment resulted in the apoptosis of the renal tubular epithelial cells and inflammatory response in a mouse model and human renal proximal tubular epithelial cells (HK-2). The differentially expressed genes (DEGs) of the transcriptome data were determined, and the results showed that lncRNA XLOC_032768 expression was significantly repressed by cisplatin treatment. This result was validated by an RT-qPCR experiment on in vivo and in vitro models. The overexpression of XLOC_032768 significantly inhibited the cisplatin-induced apoptosis and inflammatory response in HK-2 cells and mouse exposed to cisplatin. RNA sequencing analysis further confirmed that XLOC_032768 could regulate tumor necrosis factor (TNF)-α in the cisplatin-induced apoptosis of HK-2 cells in trans-manner. TNF-α inhibition also ameliorated cisplatin-induced apoptosis of renal tubular epithelial cells and renal structural damage. As such, XLOC_032768 suppressed cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α. LncRNA XLOC_032768 is a potential novel agent to reduce cisplatin-induced nephrotoxicity.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Cisplatin; Nephrotoxicity; lncRNA XLOC_032768

Mesh:

Substances:

Year:  2020        PMID: 32278129     DOI: 10.1016/j.intimp.2020.106472

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

Review 1.  Cisplatin nephrotoxicity: new insights and therapeutic implications.

Authors:  Chengyuan Tang; Man J Livingston; Robert Safirstein; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2022-10-13       Impact factor: 42.439

Review 2.  The Intersection of Acute Kidney Injury and Non-Coding RNAs: Inflammation.

Authors:  Bojun Li; Fangyou Lin; Yuqi Xia; Zehua Ye; Xinzhou Yan; Baofeng Song; Tianhui Yuan; Lei Li; Xiangjun Zhou; Weimin Yu; Fan Cheng
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

Review 3.  An Update of Long-Noncoding RNAs in Acute Kidney Injury.

Authors:  Lina Yang; Bo Wang; Liang Ma; Ping Fu
Journal:  Front Physiol       Date:  2022-03-08       Impact factor: 4.566

Review 4.  Non-Coding RNAs in Kidney Diseases: The Long and Short of Them.

Authors:  Juan Antonio Moreno; Eya Hamza; Melania Guerrero-Hue; Sandra Rayego-Mateos; Cristina García-Caballero; Mercedes Vallejo-Mudarra; Laurent Metzinger; Valérie Metzinger-Le Meuth
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 5.  Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update.

Authors:  Pía Loren; Nicolás Saavedra; Kathleen Saavedra; Tomás Zambrano; Patricia Moriel; Luis A Salazar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-21

6.  Identification of inflammatory response and alternative splicing in acute kidney injury and experimental verification of the involvement of RNA‑binding protein RBFOX1 in this disease.

Authors:  Fangyou Lin; Lei Xu; Run Yuan; Shangting Han; Jinna Xie; Kun Jiang; Bojun Li; Weimin Yu; Ting Rao; Xiangjun Zhou; Fan Cheng
Journal:  Int J Mol Med       Date:  2022-01-21       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.